Clinical Trials Directory

We are doing this study to compare 2 different procedures for treating cervical cancer and find out which approach has the best outcomes for patients. The two procedures that we will compare are open surgery with a single large incision (laparotomy) and robotic assisted laparoscopy (small incision surgery). We do not know which option is preferable in most cases, and we hope this study can help us find out which procedure is the better choice for patients.

We are doing this study to find out if an investigational drug called belumosudil (the study drug) is an option for the treatment of chronic lung allograft dysfunction (CLAD). The study drug is taken by mouth.

We are doing this study to understand how sex hormones (chemicals that tell cells and body parts to do certain things), such as estrogens and androgens, impact skin diseases like hidradenitis suppurativa (HS). To better understand this, we are enrolling both people who have diagnosed skin diseases and healthy volunteers who have no skin issues.

We are doing this study so that we can build a risk model that helps healthcare professionals better understand which children may have more trouble after a concussion. We collect data through surveys and saliva samples over the course of 1 year. Our ultimate goal is to improve recovery and support for kids with concussions.

In this study, researchers will ask people to answer surveys over time. The surveys ask about daily life after transplant, whether they still have help from caregivers after the first few months, and if their workplace offers support or changes to help them return to work. The surveys also ask about money worries, job plans, and decisions about going back to work after the transplant.

We are doing this study to compare the early treatment (before you have cancer symptoms) of Venetoclax and Obitnutuzumab (V-O) to the usual treatment of V-O after you have cancer symptoms. This study will help doctors figure out if early treatment is better, the same, or worse than the usual approach of waiting until the patient has cancer symptoms before starting treatment.